Market revenue in 2024 | USD 224.6 million |
Market revenue in 2030 | USD 432.0 million |
Growth rate | 11.5% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.42% in 2024. Horizon Databook has segmented the Germany pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The German pancreatic cancer treatment market is a critical component of the European cancer treatment landscape, with steady growth fueled by increasing disease incidence and advancements in therapeutic approaches.
Germany, with its well-established healthcare system, remains a key market player in Europe. According to WHO, in 2022, total 21,869 new cases of pancreatic cancer were diagnosed in Germany, contributing to one of the highest mortality rates associated with the disease.
The market is characterized by the dominance of chemotherapy as the primary treatment modality, including drugs such as gemcitabine and nab-paclitaxel, which are frequently used in advanced-stage cases. The market is evolving with the integration of targeted therapies.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany pancreatic cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Germany pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account